surgical-oncology team are the two most important factors preveting deaths from breast cancer. Screening Mammogram guidelines have been established as per risk stratification of patient populations and latest scientific…
applied as noninvasive, efficient and satisfactory molecular tools to monitor and predict the response to chemotherapy for breast cancer. Objective: This study was intended to explore the potential application…
ctDNA), have emerged as a non-invasive tool for diagnosis, monitoring, and treatment personalization in gynecologic cancers, including ovarian, endometrial, and cervical cancers. This article reviews the applications of…
monitoring drug treatment effects to ensure safe and effective therapy. While monitoring response to treatment is vital in cancer management, reliable biomarkers for non-invasive, longitudinal, and real-time evaluations…
viral and anti-cancer drugs. The present contribution is to review the literature data and our own experience with regard to the value of a leukocyte monitoring for effi cient ... immunosuppression, of anti-viral or…
surveillance were matched 1:15. 5.8% of patients outside of surveillance had stage I cancer, whereas 38.7% of surveillance patients had PDAC (odds ratio [OR], 0.09; (0.04–0.19), 95 percent ... adjusted lead times…
RECIST 1.1 tumour size measurements on CT/MRI are the mainstay of cancer therapy monitoring. However, bone metastases are consistently difficult to evaluate for hormonal therapy response often escaping ... linear…
cancer patients. During a nonoperative treatment for a patient with advanced esophageal cancer, we performed dynamic monitoring of circulating tumor cell counts to evaluate the efficacy. Compared with the clinical…
peripheral blood of patients with cancer may be a less invasive and more sensitive way to monitor or possibly predict responses to anti-PD-1 therapy, although future prospective analyses ... group has also established…
evaluate drug utilization pattern of anticancer drugs and to monitor the adverse drug reactions (ADR’s) in cancer patients receiving chemotherapy. Newly diagnosed patients of carcinoma which required treatment with